- Home
- WES vs ILMN Comparison
WES vs ILMN Comparison
Compare WES & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WES
- ILMN
- Stock Information
- Founded
- WES 2007
- ILMN 1998
- Country
- WES United States
- ILMN United States
- Employees
- WES N/A
- ILMN N/A
- Industry
- WES Natural Gas Distribution
- ILMN Medical Specialities
- Sector
- WES Utilities
- ILMN Health Care
- Exchange
- WES Nasdaq
- ILMN Nasdaq
- Market Cap
- WES 15.0B
- ILMN 15.3B
- IPO Year
- WES 2008
- ILMN 2000
- Fundamental
- Price
- WES $38.43
- ILMN $120.77
- Analyst Decision
- WES Hold
- ILMN Hold
- Analyst Count
- WES 5
- ILMN 15
- Target Price
- WES $40.00
- ILMN $114.93
- AVG Volume (30 Days)
- WES 1.9M
- ILMN 2.0M
- Earning Date
- WES 11-04-2025
- ILMN 10-30-2025
- Dividend Yield
- WES 9.52%
- ILMN N/A
- EPS Growth
- WES N/A
- ILMN N/A
- EPS
- WES 3.38
- ILMN 4.46
- Revenue
- WES $3,740,425,000.00
- ILMN $4,288,000,000.00
- Revenue This Year
- WES $7.07
- ILMN N/A
- Revenue Next Year
- WES $7.20
- ILMN $2.22
- P/E Ratio
- WES $11.32
- ILMN $27.45
- Revenue Growth
- WES 5.81
- ILMN N/A
- 52 Week Low
- WES $33.60
- ILMN $68.70
- 52 Week High
- WES $43.33
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- WES 52.10
- ILMN 66.55
- Support Level
- WES $37.01
- ILMN $94.00
- Resistance Level
- WES $38.92
- ILMN $126.00
- Average True Range (ATR)
- WES 0.67
- ILMN 5.22
- MACD
- WES 0.01
- ILMN 2.69
- Stochastic Oscillator
- WES 69.55
- ILMN 83.66
About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.